We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead Sciences said Friday that it had completed its $21 billion purchase of Immunomedics that will extend Gilead’s reach into oncology drugs. Read More
Roche and Atea Pharmaceuticals have struck a deal to develop a COVID-19 antiviral pill, AT-527, currently being evaluated in a phase 2 study. Read More
Dr. Reddy’s Laboratories, one of India’s largest pharmaceutical companies, announced Thursday that it has temporarily shut down all of its data center services in response to a cyberattack. Read More
Endo International announced that it will purchase the biopharmaceutical company BioSpecifics Technologies for approximately $540 million giving the company complete control over two promising collagenase-based therapies. Read More
China’s state-owned pharmaceutical company Sinopharm is gearing up to manufacture 1 billion doses of its two potential coronavirus vaccines in 2021. Read More
Roche has partnered with Dyno Therapeutics to develop adeno-associated virus (AAV) vectors for gene therapies for nervous system diseases and liver-directed treatments, part of the Swiss drugmaker’s push to expand into gene therapies. Read More
Barely more than one in four air cargo companies that will be involved in distributing COVID-19 vaccines are well-prepared to do so, a new survey has found. Read More
The British Embassy in Bangkok announced Monday that Thailand will pitch in to manufacture AstraZeneca’s COVID-19 vaccine candidate to bolster the supply in southeast Asia. Read More
Mallinckrodt filed for bankruptcy protection Monday as the company faces billions of dollars in legal liabilities over its role in the nation’s opioid epidemic. Read More